Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by irreversible lung dysfunction caused by fibroblast proliferation and excessive collagen deposition, is the result of persistent chronic inflammation of the lung parenchyma. Although the pathogenesis is not fully underst...
Saved in:
| Main Authors: | Dongyang Gao, Wenli Gao, Zhiguang Zhai, Wenxiang Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Pharmaceutical Science Advances |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2773216923000284 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
by: Zhe Chen, et al.
Published: (2025-01-01) -
The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice
by: Remo Castro Russo, et al.
Published: (2024-12-01) -
Identification and Analysis of Key Immune- and Inflammation-Related Genes in Idiopathic Pulmonary Fibrosis
by: Tan Y, et al.
Published: (2025-02-01) -
Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01) -
The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis
by: Tao Chen, et al.
Published: (2024-12-01)